152 related articles for article (PubMed ID: 24554709)
1. Increased IL-17 and IL-21 producing TCRαβ+CD4-CD8- T cells in Chinese systemic lupus erythematosus patients.
Wang HX; Chu S; Li J; Lai WN; Wang HX; Wu XJ; Kang X; Qiu YR
Lupus; 2014 Jun; 23(7):643-54. PubMed ID: 24554709
[TBL] [Abstract][Full Text] [Related]
2. Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus.
Yang XY; Wang HY; Zhao XY; Wang LJ; Lv QH; Wang QQ
J Clin Immunol; 2013 May; 33(4):767-74. PubMed ID: 23435610
[TBL] [Abstract][Full Text] [Related]
3. Arthritis in systemic lupus erythematosus is characterized by local IL-17A and IL-6 expression in synovial fluid.
Sippl N; Faustini F; Rönnelid J; Turcinov S; Chemin K; Gunnarsson I; Malmström V
Clin Exp Immunol; 2021 Jul; 205(1):44-52. PubMed ID: 33576004
[TBL] [Abstract][Full Text] [Related]
4. Double-negative (CD4-CD8-) TCRalphabeta+ cells in patients with systemic lupus erythematosus.
Liu MF; Li JS; Weng TH; Lei HY
Scand J Rheumatol; 1998; 27(2):130-4. PubMed ID: 9572639
[TBL] [Abstract][Full Text] [Related]
5. Immunoregulation therapy changes the frequency of interleukin (IL)-22+ CD4+ T cells in systemic lupus erythematosus patients.
Zhao L; Ma H; Jiang Z; Jiang Y; Ma N
Clin Exp Immunol; 2014 Jul; 177(1):212-8. PubMed ID: 24635166
[TBL] [Abstract][Full Text] [Related]
6. Expressions of IL-22 in circulating CD4+/CD8+ T cells and their correlation with disease activity in SLE patients.
Qin WZ; Chen LL; Pan HF; Leng RX; Zhai ZM; Wang C; Li RJ; Wang S; Wang HP; Ye DQ
Clin Exp Med; 2011 Dec; 11(4):245-50. PubMed ID: 21487830
[TBL] [Abstract][Full Text] [Related]
7. Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus.
Dolff S; Abdulahad WH; Westra J; Doornbos-van der Meer B; Limburg PC; Kallenberg CG; Bijl M
Arthritis Res Ther; 2011; 13(5):R157. PubMed ID: 21959034
[TBL] [Abstract][Full Text] [Related]
8. Increased interleukin-23 receptor(+) T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.
Puwipirom H; Hirankarn N; Sodsai P; Avihingsanon Y; Wongpiyabovorn J; Palaga T
Arthritis Res Ther; 2010; 12(6):R215. PubMed ID: 21110900
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
10. Decreased plasma IL-22 levels and correlations with IL-22-producing T helper cells in patients with new-onset systemic lupus erythematosus.
Lin J; Yue LH; Chen WQ
Scand J Immunol; 2014 Feb; 79(2):131-6. PubMed ID: 24313261
[TBL] [Abstract][Full Text] [Related]
11. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus.
Shah K; Lee WW; Lee SH; Kim SH; Kang SW; Craft J; Kang I
Arthritis Res Ther; 2010; 12(2):R53. PubMed ID: 20334681
[TBL] [Abstract][Full Text] [Related]
12. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
[TBL] [Abstract][Full Text] [Related]
13. CD3
Mohd Shukri ND; Farah Izati A; Wan Ghazali WS; Che Hussin CM; Wong KK
Front Immunol; 2021; 12():675250. PubMed ID: 34149710
[TBL] [Abstract][Full Text] [Related]
14. Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus.
Wong CK; Wong PT; Tam LS; Li EK; Chen DP; Lam CW
Clin Exp Immunol; 2010 Jan; 159(1):11-22. PubMed ID: 19843090
[TBL] [Abstract][Full Text] [Related]
15. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y
Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
[TBL] [Abstract][Full Text] [Related]
16. Elevated circulating CD4+ ICOS+ Foxp3+ T cells contribute to overproduction of IL-10 and are correlated with disease severity in patients with systemic lupus erythematosus.
Liu Y; Zhu T; Cai G; Qin Y; Wang W; Tang G; Zhao D; Shen Q
Lupus; 2011 May; 20(6):620-7. PubMed ID: 21558138
[TBL] [Abstract][Full Text] [Related]
17. Expression profile of PU.1 in CD4
Xiang N; Fang X; Sun XG; Zhou YB; Ma Y; Zhu C; Li XP; Wang GS; Tao JH; Li XM
Clin Exp Med; 2021 Nov; 21(4):621-632. PubMed ID: 33966135
[TBL] [Abstract][Full Text] [Related]
18. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
19. IL-17 in cutaneous lupus erythematosus.
Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
[TBL] [Abstract][Full Text] [Related]
20. The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus.
Fritsch-Stork R; Müllegger D; Skriner K; Jahn-Schmid B; Smolen JS; Steiner G
Arthritis Res Ther; 2006; 8(4):R118. PubMed ID: 16859514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
